Cdc42: Role in Cancer Management

Chem Biol Drug Des. 2015 Oct;86(4):432-9. doi: 10.1111/cbdd.12556. Epub 2015 Apr 7.

Abstract

Contribution of Cdc42, a member of Rho family, has been characterized for the beginning of variety of cellular responses including cellular transformation, cell division, cell invasion, migration, invadopodia formation, enzyme activity, filopodia formation, and cell polarity in cells. Deregulation of Cdc42 can alter the normal functioning of the cells, responsible for the initiation of signaling pathways and is correlated with several pathogenic processes such as cancer. Therefore, maintaining the level of Cdc42 and its effectors in cells, tumor progression can be controlled. Therefore, it can be suggested that deeper understanding about the Cdc42 contribution in cancer cell progression at molecular level can approach to the development of Cdc42 inhibitors in cancer management.

Keywords: Cdc42; GTPase-activating proteins; cell division control protein; guanine exchange factor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemical synthesis
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / therapeutic use
  • Cell Division / drug effects
  • Cell Movement / drug effects
  • Enzyme Inhibitors* / chemical synthesis
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / therapeutic use
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Neoplasms / pathology
  • cdc42 GTP-Binding Protein / antagonists & inhibitors*
  • cdc42 GTP-Binding Protein / metabolism

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • cdc42 GTP-Binding Protein